Filing Flows

Filing Flows › Comparisons › WVE vs OCUL

Wave Life Sciences vs Ocular Therapeutix: WVE and OCUL compared

Wave Life Sciences is the larger company: $13.2M of revenue in its latest quarter (Q3 2026) against $12.9M for Ocular Therapeutix (Q3 2026). Wave Life Sciences is growing faster (+73% against -12% a year earlier). Wave Life Sciences is more profitable, with an operating margin of -502.0% against -760.1%.

Wave Life Sciences vs Ocular Therapeutix, latest quarterWave Life Sciences vs Ocular Therapeutix, latest quarterWave Life Sciences (WVE)Ocular Therapeutix (OCUL)Revenue$13.2M$12.9MRevenue growth, Y/Y+73%-12%Operating margin-502.0%-760.1%Net margin-470.5%-736.2%

Where the money goes: WVE and OCUL

Wave Life Sciences (WVE) · Q3 2026

Wave Life Sciences, Q3 2026: revenue $13.2M (+73% year over year), operating margin -502.0%, net loss $61.9M, operating cash flow −$60.1M. The chart follows the revenue to costs, profit and cash.

Ocular Therapeutix (OCUL) · Q3 2026

Ocular Therapeutix, Q3 2026: revenue $12.9M (-12% year over year), operating margin -760.1%, net loss $94.8M, operating cash flow −$65.6M. The chart follows the revenue to costs, profit and cash.

Wave Life Sciences (WVE)Ocular Therapeutix (OCUL)
Latest quarterQ3 2026Q3 2026
Revenue$13.2M$12.9M
Revenue growth, Y/Y+73%-12%
Operating margin-502.0%-760.1%
Net earnings−$61.9M−$94.8M
Net margin-470.5%-736.2%
Operating cash flow−$60.1M−$65.6M

Questions

Which is bigger, Wave Life Sciences or Ocular Therapeutix?

Wave Life Sciences is the larger company: $13.2M of revenue in its latest quarter (Q3 2026) against $12.9M for Ocular Therapeutix (Q3 2026).

Is Wave Life Sciences or Ocular Therapeutix growing faster?

Wave Life Sciences is growing faster (+73% against -12% a year earlier).

Which is more profitable, Wave Life Sciences or Ocular Therapeutix?

Wave Life Sciences is more profitable, with an operating margin of -502.0% against -760.1%.

More: Wave Life Sciences earnings · how Wave Life Sciences makes money · Ocular Therapeutix earnings · how Ocular Therapeutix makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 27, 2026; 10-Q filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.